EP2535337
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form
:
EP einkaleyfi: Þýðing ekki lögð inn:
18.7.2006:
23.8.2017:
12160493.8
:
17.7.2026
:
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form
18.7.2006
23.8.2017
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
Novartis Pharma GmbH:
Brunner Strasse 59, 1230, Wien, AT
:
Manley, Paul W.:
Arlesheim, CH
:
Shieh, Wen-Chung:
Berkeley Heights, NJ, US
:
Sutton, Paul Allen:
Parsippany, NJ, US
:
Karpinski, Piotr H.:
Lincoln Park, NJ, US
:
Wu, Raeann:
Pine Brook, NJ, US
:
Monnier, Stéphanie:
Raedersheim, FR
:
Brozio, Jörg:
Basel, CH
:
701405 P:
20.7.2005:
US
:
716214 P:
12.9.2005:
US
:
C07D 401/14, A61K 31/506, A61P 35/00